BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15038871)

  • 1. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
    Richardson D; Lamba H
    Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

  • 3. More uses for tenofovir?
    AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
    [No Abstract]   [Full Text] [Related]  

  • 4. Tenofovir helps beat hepatitis B.
    TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment: a tale of two viruses.
    Dieterich DT
    AIDS Read; 2002 Oct; 12(10):448-9. PubMed ID: 12408102
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
    van Bömmel F; Wünsche T; Schürmann D; Berg T
    Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir DF trial announced by Gilead.
    Eagan L
    Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenofovir--long term results from first-line therapy.
    TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
    [No Abstract]   [Full Text] [Related]  

  • 10. Tenofovir: FDA hearing on important new antiretroviral.
    James JS
    AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
    Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
    Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir approved: broad indication.
    James JS
    AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenofovir (Viread(R)) access for poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):6-7. PubMed ID: 12569875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cambodia stops important tenofovir prevention trial.
    James JS
    AIDS Treat News; 2004 Jul; (403):4-5. PubMed ID: 15386853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report.
    Alcaide ML; Kolber M; Jayaweera D
    Int J STD AIDS; 2002 Nov; 13(11):795-6. PubMed ID: 12437905
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.